Neglected tropical diseases

Dada Group's Impressive 2022 Year in Review

Retrieved on: 
Tuesday, January 3, 2023
Accidental Death and Disability: The Neglected Disease of Modern Society, GMV, Neglected tropical diseases, Consumption, Family, IPhone, RADIUS, Employment, JDDJ, Growth, Business, JD, Huang Haibo (TV host), Economic development, JD.com, Decathlon, CCFA, White paper, Online shopping, Warehouse

In 2022, Dada Group has been spearheading a slew of initiatives which have expedited the digital transformation of brick-and-mortar stores.

Key Points: 
  • In 2022, Dada Group has been spearheading a slew of initiatives which have expedited the digital transformation of brick-and-mortar stores.
  • JD.com's investment in Dada successfully completed by end of February 2022.
  • Dada Group and JD.com are at the forefront of the development of on-demand retail and delivery.
  • In May, Dada Group released a White Paper "On-Demand Retail Fulfillment Services 2022", in collaboration with LOGResearch, a think tank expertizing in supply chain and logistics.

Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging

Retrieved on: 
Thursday, December 22, 2022
Quality of life, Daiichi Sankyo, Climate change, Recycling, Patient, Vaccine, Hematology, Sustainable Development Goals, Anxiety, Health, United Nations Sustainable Development Group, TSE, Knowledge, GHG, TAK, Astellas Pharma, Life, Marketing, Modality, Carbon, R, Neglected tropical diseases, Multimedia, Blister, Biology, Cardiovascular disease, Takeda Pharmaceutical Company, Water, Materiality, Sustainable development, Investment, Cancer, Sustainability, Neurology, Pharmaceutical industry, Takeda, Limited, Neuroscience, Eisai, Gastroenterology

(TSE: 4502 / NYSE:TAK, President and CEO Christophe Weber, "Takeda") today announced that the four companies have agreed the collaboration to reduce environmental burden in the field of pharmaceutical packaging.

Key Points: 
  • (TSE: 4502 / NYSE:TAK, President and CEO Christophe Weber, "Takeda") today announced that the four companies have agreed the collaboration to reduce environmental burden in the field of pharmaceutical packaging.
  • Astellas, Eisai, Daiichi Sankyo, and Takeda aim to ensure that society benefits from this collaboration to harmonize corporate activities with the global environment.
  • In the future, the four companies expect to expand this collaboration beyond the four companies by calling on other companies in order to reduce further environmental burden.
  • Astellas has set "Deepen our engagement in sustainability" as one of the strategic goals in its Corporate Strategic Plan 2021 .

From Trends to Strategies: The Role of Social Commerce Unveiled in Snapchat and Shoplazza White Paper

Retrieved on: 
Monday, December 19, 2022
AR, Consumer, UGC, E-commerce, Role, Marketing, Social commerce, Multimedia, Neglected tropical diseases, Research, White paper, Social media, Ernst Loosen, Software as a service, COVID-19, Advertising, Online shopping

BEIJING, Dec. 19, 2022 /PRNewswire/ -- The global eCommerce SaaS provider Shoplazza published an in-depth white paper "From Trends to Strategies: The Role of Social Commerce" with Snapchat.

Key Points: 
  • BEIJING, Dec. 19, 2022 /PRNewswire/ -- The global eCommerce SaaS provider Shoplazza published an in-depth white paper "From Trends to Strategies: The Role of Social Commerce" with Snapchat.
  • The whitepaper outlays why social commerce is the new norm for online shopping and how to win the hearts of consumers with social commerce strategies.
  • The white paper "From Trends to Strategies: The Role of Social Commerce '' examines in-depth research and analysis on social commerce jointly by the global award-winning Shopping Cart SaaS company Shoplazza and the popular visual messaging app Snapchat.
  • From emerging opportunities of social commerce to essential social commerce strategies, this white paper will guide global merchants to adopt and implement various strategies to empower their market competitiveness.

GHIT Fund Secures US$20 Million Pledge From Wellcome over 5 Years

Retrieved on: 
Monday, December 5, 2022
Tropical disease, United Nations, Global Health Innovative Technology Fund, Infection, Government of Japan, Neglected tropical diseases, Life, Global health, Partnership, Science, Research, Tuberculosis, Climate, UNDP, Malaria, United Nations Development Programme, Drug development, Bill, Mental health, Vaccine, Bill & Melinda Gates Foundation, TB, Health, PPP, Pharmaceutical industry, Wellcome

TOKYO, Dec. 5, 2022 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today that it has secured a pledge from global charitablefoundation Wellcome for GHIT Fund's third five-year plan, GHIT 3.0 (from FY2023 to FY 2027*1) of US$20 million (approximately 2.7 billion yen*2)over five years.

Key Points: 
  • TOKYO, Dec. 5, 2022 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today that it has secured a pledge from global charitablefoundation Wellcome for GHIT Fund's third five-year plan, GHIT 3.0 (from FY2023 to FY 2027*1) of US$20 million (approximately 2.7 billion yen*2)over five years.
  • "We are incredibly grateful for Wellcome's commitment to the GHIT Fund.
  • The GHIT fund addresses this enduring gap by investing in product R&D and by leveraging scientific expertise and product development capabilities in Japan."
  • Wellcome is proud to be supporting the GHIT Fund whose work will help us develop lifesaving vaccines, treatments and tests for people everywhere."

EISAI TO PRESENT LATEST DATA ON FYCOMPA® (PERAMPANEL) CIII AT THE 76TH AMERICAN EPILEPSY SOCIETY (AES) ANNUAL MEETING

Retrieved on: 
Wednesday, November 23, 2022
Suicidal ideation, Neglected tropical diseases, Marketing, Clinical trial, Epilepsy, Headache, Hospital, Anticonvulsant, AED, Risk, Plasma, Behavior, Anxiety, Seizure, Weight gain, Fever, Bruise, Death, Anger, Disease, DRESS, Vomiting, Depression, Mortality, Gait, Vertigo, Falls, Health, Somnolence, Patient, Pharmacotherapy, Ageing, Lymphadenopathy, Irritability, Dizziness, Ataxia, Head Injuries, Caregiver, Aggression, Human, Rash, Psychiatry, Self-harm, Central nervous system, United Nations Sustainable Development Group, AMPA, Fatigue, Fracture, Perampanel, Sustainable Development Goals, CNS, Homicidal ideation, Neurology, Nausea, Abdominal pain, POS, SUDEP, CIII, Personality, Pharmaceutical industry, Residential care, Eisai

NUTLEY, N.J., Nov. 23, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will have a total of 34 posters, including the latest data on its in-house discovered and developed anti-seizure medication (ASM) FYCOMPA® (perampanel) CIII, at the 76th American Epilepsy Society Annual Meeting (AES 2022), to be held in Nashville, Tennessee and virtually from December 2-6, 2022.

Key Points: 
  • Epilepsy is one of the most common neurological disorders, which affects 3.4 million people in the United States, including 470,000 children.
  • Partial-onset seizures are the most common types of seizures seen in people with epilepsy, accounting for 60 percent of all seizures.
  • Missed medication doses are the number one cause of breakthrough seizures, which can cause significant injury to patients.
  • Physicians are advised to recommend that pregnant patients taking FYCOMPA enroll in the North American Antiepileptic Drug (NAAED) Pregnancy Registry.

The 6th Hainan International Health Industry Expo 2022 kicks off in Haikou, China

Retrieved on: 
Tuesday, November 22, 2022
Growth, Conference, Health, World Health Organization, International One Design, Hainan International Convention And Exhibition Center, South Australian Health and Medical Research Institute, Environment, Chinese People's Political Consultative Conference, Kenya Medical Research Institute, Therapy, Neglected tropical diseases, Chinese Academy of Tropical Agricultural Sciences, Climate, Infection, White paper, Alternative medicine, CAS, Wellness, Chinese Academy of Sciences, CPC, Health care, Convention center, CAE, COVID-19, Chinese Academy of Engineering, Medical device, Development, Pharmaceutical industry

HAIKOU, China, Nov. 22, 2022 /PRNewswire/ -- The 6th Hainan International Health Industry Expo 2022 kicks off at the Hainan International Convention and Exhibition Center in Haikou, Hainan province, China recently.

Key Points: 
  • HAIKOU, China, Nov. 22, 2022 /PRNewswire/ -- The 6th Hainan International Health Industry Expo 2022 kicks off at the Hainan International Convention and Exhibition Center in Haikou, Hainan province, China recently.
  • With three theme pavilions: Regional Characteristics, Innovative Drugs and Medical Devices, and Health and Wellness, the 40,000+ square-meter expo attracted over 500 exhibitors, including many leading companies in their respective fields.
  • Founded in 2017, the Hainan International Health Industry Expo has been successfully held for five years in a row.
  • At the China International Healthcare Industry Summit and International One Health Conference, a number of distinguished guests who are committed to the global health industry delivered keynote speeches on multiple key topics, including the development of the Chinese health sector in the post-pandemic era, in addition to engaging in expert talks, experience sharing, industry-focused discussions and resource promotion.

The 6th Hainan International Health Industry Expo 2022 kicks off in Haikou, China

Retrieved on: 
Tuesday, November 22, 2022
Growth, Conference, Health, World Health Organization, International One Design, Hainan International Convention And Exhibition Center, South Australian Health and Medical Research Institute, Environment, Chinese People's Political Consultative Conference, Kenya Medical Research Institute, Therapy, Neglected tropical diseases, Chinese Academy of Tropical Agricultural Sciences, Climate, Infection, White paper, Alternative medicine, CAS, Wellness, Chinese Academy of Sciences, CPC, Health care, Convention center, CAE, COVID-19, Chinese Academy of Engineering, Medical device, Development, Pharmaceutical industry

HAIKOU, China, Nov. 22, 2022 /PRNewswire/ -- The 6th Hainan International Health Industry Expo 2022 kicks off at the Hainan International Convention and Exhibition Center in Haikou, Hainan province, China recently.

Key Points: 
  • HAIKOU, China, Nov. 22, 2022 /PRNewswire/ -- The 6th Hainan International Health Industry Expo 2022 kicks off at the Hainan International Convention and Exhibition Center in Haikou, Hainan province, China recently.
  • With three theme pavilions: Regional Characteristics, Innovative Drugs and Medical Devices, and Health and Wellness, the 40,000+ square-meter expo attracted over 500 exhibitors, including many leading companies in their respective fields.
  • Founded in 2017, the Hainan International Health Industry Expo has been successfully held for five years in a row.
  • At the China International Healthcare Industry Summit and International One Health Conference, a number of distinguished guests who are committed to the global health industry delivered keynote speeches on multiple key topics, including the development of the Chinese health sector in the post-pandemic era, in addition to engaging in expert talks, experience sharing, industry-focused discussions and resource promotion.

GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases

Retrieved on: 
Friday, November 11, 2022
Wolbachia, Health, Adult, Investment, Wellcome, Vaccine, United Nations, Global Health Innovative Technology Fund, Partnership, Research, Lymphatic filariasis, Bill & Melinda Gates Foundation, United Nations Development Programme, Malaria, US, Government of Japan, PPP, Lymph, Degenerative disease, Onchocerciasis, Neglected tropical diseases, Tuberculosis, Patient, Elephantiasis, Bill, UNDP, CEO, Pharmaceutical industry

TOKYO, Nov. 10, 2022 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of approximately 790 million yen (US$5.3 million*) to invest in product development for lymphatic filariasis and onchocerciasis, two neglected tropical diseases (NTDs).

Key Points: 
  • TOKYO, Nov. 10, 2022 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of approximately 790 million yen (US$5.3 million*) to invest in product development for lymphatic filariasis and onchocerciasis, two neglected tropical diseases (NTDs).
  • Neglected tropical diseases caused by parasitic infection: New drug development for lymphatic filariasis and onchocerciasis
    Lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness) are two neglected tropical diseases that are caused by parasitic worms.
  • The GHIT Fund invests and manages an R&D portfolio of development partnerships aimed at neglected diseases, such as malaria, tuberculosis and neglected tropical diseases that afflict the world's vulnerable and underserved populations.
  • The GHIT Fund mobilizes the Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases, in collaboration with global partners.

Frost & Sullivan Released White Paper for Global Graphite and Graphene Markets

Retrieved on: 
Saturday, November 5, 2022
White paper, CO2, Electronics, CAGR, Industry, Biology, Semiconductor, Public sector, Neglected tropical diseases, Massachusetts Institute of Technology, Bachelor of Engineering, MIT, Graphite, Attention, Frost & Sullivan, Environment, Regeneration, ILP, Frost, Biomass, Carbon, Policy, Efficiency, Carbon fibers, Renewable energy, Graphene, EU

Shanghai, China--(Newsfile Corp. - November 5, 2022) - Frost & Sullivan has conducted extensive investigation across the global graphite and graphene industry chain, and released the White Paper for Global Graphite and Graphene Markets, which focuses on the recent development of global graphite and graphene industry as well as new growth opportunities.

Key Points: 
  • Shanghai, China--(Newsfile Corp. - November 5, 2022) - Frost & Sullivan has conducted extensive investigation across the global graphite and graphene industry chain, and released the White Paper for Global Graphite and Graphene Markets, which focuses on the recent development of global graphite and graphene industry as well as new growth opportunities.
  • The global graphene market size was USD12.6 billion in 2021, with Asia Pacific, North America, and Europe accounting for 54.4%, 21.2%, and 20.0% respectively.
  • The global graphite and graphene market is expected to reach USD30.4 billion and USD71.9 billion, respectively in 2026.
  • Frost & Sullivan's White Paper for Global Graphite and Graphene Markets 2017-2026 highlights the following:
    Global graphite industry (market size, etc.

Carewell Releases White Paper Identifying Critical Gaps in Family Caregivers' Support Systems

Retrieved on: 
Tuesday, November 1, 2022
Government, Awareness, Gaps, White paper, Caregiver, Family, Accidental Death and Disability: The Neglected Disease of Modern Society, Fast Company (1918 film), Neglected tropical diseases, Residential care, Forbes

MIAMI, Nov. 1, 2022 /PRNewswire/ -- Carewell, the leading e-commerce resource for caregivers, released a White Paper today exploring the support needs of family caregivers in honor of National Family Caregivers Month. The report, titled "Supporting Family Caregivers: Identifying the Gaps in Support for America's Hidden Workforce," identifies the key areas in which caregivers need support and highlights how society, government institutions, employers, and family units can step up to assist them.

Key Points: 
  • MIAMI, Nov. 1, 2022 /PRNewswire/ -- Carewell , the leading e-commerce resource for caregivers, released a White Paper today exploring the support needs of family caregivers in honor of National Family Caregivers Month.
  • The report, titled "Supporting Family Caregivers: Identifying the Gaps in Support for America's Hidden Workforce," identifies the key areas in which caregivers need support and highlights how society, government institutions, employers, and family units can step up to assist them.
  • For National Family Caregivers Month, Carewell releases a report highlighting the gaps in support that caregivers face.
  • The White Paper is based on a survey that Carewell conducted in September 2022 on its customer base of caregivers.